Inactive Instrument
Ocata Therapeutics Inc Stock
Stocks
US67457L1008
Biotechnology & Medical Research
|
End-of-day quote
Other stock markets
|
||
| - USD | - |
|
| Manager | Title | Age | Since |
|---|---|---|---|
John Heffernan
PRN | Corporate Officer/Principal | - | 2015-02-02 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 53 | - | |
Masaaki Hirano
BRD | Director/Board Member | 59 | - |
Toru Yoshimitsu
BRD | Director/Board Member | 63 | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.03% | +2.30% | +54.92% | +111.78% | 55.58B | |
| +2.72% | +3.06% | +53.28% | +47.85% | 43.47B | |
| +1.12% | +2.79% | -13.71% | -17.53% | 22.64B | |
| +1.17% | +3.85% | +1.00% | +401.79% | 20.96B | |
| +3.81% | -4.13% | +16.62% | -30.70% | 15.79B | |
| +0.15% | +2.24% | +9.06% | -39.50% | 15.3B | |
| -0.69% | +0.82% | +27.17% | +178.31% | 13.45B | |
| +5.27% | +6.41% | +21.05% | - | 11.74B | |
| +1.61% | +1.17% | +90.79% | +212.97% | 10.96B | |
| Average | +1.80% | +0.97% | +28.91% | +108.12% | 23.32B | |
| Weighted average by Cap. | +1.71% | +1.61% | +33.77% | +100.74% |
- Stock Market
- Stocks
- Stock
Select your edition
All financial news and data tailored to specific country editions
